Advanced

Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.

Petersén, Åsa LU ; Chase, K; Puschban, Zoe LU ; DiFiglia, M; Brundin, Patrik LU and Aronin, N (2002) In Experimental Neurology 175(1). p.297-300
Abstract
A transgenic mouse model of Huntington's disease (R6/1 and R6/2 lines) expressing exon 1 of the HD gene with 115-150 CAG repeats resisted striatal damage following injection of quinolinic acid and other neurotoxins. We examined whether excitotoxin resistance characterizes mice with mutant huntingtin transgenes. In a new transgenic mouse with 3 kb of mutant human huntingtin cDNA with 18, 46, or 100 CAG repeats, we found no change in susceptibility to intrastriatal injections of the excitotoxin quinolinic acid, compared to wild-type littermates. The new transgenic mice were injected with the same dose of quinolinic acid (30 nmol) as had been the R6 mice. Our findings highlight the importance of studying pathogenetic mechanisms in different... (More)
A transgenic mouse model of Huntington's disease (R6/1 and R6/2 lines) expressing exon 1 of the HD gene with 115-150 CAG repeats resisted striatal damage following injection of quinolinic acid and other neurotoxins. We examined whether excitotoxin resistance characterizes mice with mutant huntingtin transgenes. In a new transgenic mouse with 3 kb of mutant human huntingtin cDNA with 18, 46, or 100 CAG repeats, we found no change in susceptibility to intrastriatal injections of the excitotoxin quinolinic acid, compared to wild-type littermates. The new transgenic mice were injected with the same dose of quinolinic acid (30 nmol) as had been the R6 mice. Our findings highlight the importance of studying pathogenetic mechanisms in different transgenic models of a disease. (Less)
Please use this url to cite or link to this publication:
@article{42d84e78-bc00-4337-ac17-442546151a75,
  abstract     = {A transgenic mouse model of Huntington's disease (R6/1 and R6/2 lines) expressing exon 1 of the HD gene with 115-150 CAG repeats resisted striatal damage following injection of quinolinic acid and other neurotoxins. We examined whether excitotoxin resistance characterizes mice with mutant huntingtin transgenes. In a new transgenic mouse with 3 kb of mutant human huntingtin cDNA with 18, 46, or 100 CAG repeats, we found no change in susceptibility to intrastriatal injections of the excitotoxin quinolinic acid, compared to wild-type littermates. The new transgenic mice were injected with the same dose of quinolinic acid (30 nmol) as had been the R6 mice. Our findings highlight the importance of studying pathogenetic mechanisms in different transgenic models of a disease.},
  author       = {Petersén, Åsa and Chase, K and Puschban, Zoe and DiFiglia, M and Brundin, Patrik and Aronin, N},
  issn         = {0014-4886},
  keyword      = {Huntington Disease : complications,Heterozygote,Huntington Disease : chemically induced,Human,Huntington Disease : genetics,P.H.S.,U.S. Gov't,Support,Non-P.H.S.,Non-U.S. Gov't,Species Specificity,Quinolinic Acid : administration & dosage,Neurons : pathology,Neurons : drug effects,Neurodegenerative Diseases : pathology,Neurodegenerative Diseases : complications,Neurodegenerative Diseases : chemically induced,Microinjections,Transgenic,Mice,Huntington Disease : pathology,Disease Susceptibility,Animal,Disease Models,Corpus Striatum : pathology,Cell Count,Cell Death,Corpus Striatum : drug effects},
  language     = {eng},
  number       = {1},
  pages        = {297--300},
  publisher    = {Academic Press},
  series       = {Experimental Neurology},
  title        = {Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.},
  url          = {http://dx.doi.org/10.1006/exnr.2002.7885},
  volume       = {175},
  year         = {2002},
}